Skip to content

CITIUS ONCOLOGY, INC.

CTOR

CIK 0001851484

← back to feed
Revenue (TTM)
—
Q2 May 2026
Net Income (TTM)
−$45.25M
−17.1% YoY Q2 May 2026
EPS Diluted (TTM)
−$0.52
−9.7% YoY Q2 May 2026
Gross Margin
—
Q2 May 2026
Operating Margin
—
Q2 May 2026
Net Margin
—
Q2 May 2026
Free Cash Flow (TTM)
—
Q2 May 2026
Cash
$2.63M
Q2 May 2026
Total Debt
—
Q2 May 2026
Shares Outstanding
92.98M sh
Q2 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Recent filings